Bioactive Compound Details

BioIDbio66878
NameALPROSTADIL
ChEMBL IDCHEMBL495
Molecular FormulaC20H34O5
Molecular Weight354.49
Molecular Weight (Monoisotopic)354.2406
TypeSmall molecule
Max PhasePhase 4
Target IDTar71
Target NameNone
SynonymsALPROSTADIL|CAVERJECT|CAVERJECT IMPULSE|EDEX|NSC-165559|ONO-1608|PGE1|PROSTAGLANDIN E1|PROSTIN VR|PROSTIN VR PEDIATRIC|U-10,136|U-10136|VIRIDAL 10|VIRIDAL 20|VIRIDAL 5|VIRIDAL DUO|VITAROS
SmilesCCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O
InchiInChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1
Inchi KeyGMVPRGQOIOIIMI-DWKJAMRDSA-N
Molecular SpeciesACID
Targets158.0
Bioactivities1299.0
Np Likeness Score1.7
Records Key['149 (Prostaglandin E1)', '5 (isomer)', 'SID144204033', '2b (PGE1)', 'A (PGE1)', '4', 'PGE1', 'Alprostadil', 'Prostaglandin E1', 'PGE1', 'PGE1', 'PGE1', 'Alprostadil', 'Alprostadil', 'PGE1', 'Prostaglandin E1', 'PGE1', 'prostaglandin e1', 'PGE-1', '2, PGE1', 'PGE1', 'Prostaglandin E1', 'Alprostadil', 'Prostaglandin E1', 'Prostaglandin E1', 'ALPROSTADIL', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostoglandin E1 (table SV)', 'Alprostadil', 'Alprostadil', 'ALPROSTADIL', 'PGE1', 'PGE1', 'PGE1', 'PGE1', 'l-PGE1', 'PGE1', 'PGE1', 'Alprostadil', 'Alprostadil', 'Alprostadil脗', 'SID49681576', 'ALPROSTADIL', 'Prostaglandin E1', 'Alprostadil脢', 'ALPROSTADIL', 'alprostadil', 'alprostadil', 'ALPROSTADIL', 'ALPROSTADIL', 'ALPROSTADIL', 'COVC-0673218770', 'ALPROSTADIL', 'SAM001246840', 'alprostadil', 'EUB0000980a', 'EUB0000980a', 'EUB0000980a', 'EUB0000980a', '3; PGE1', 'EUB0000980a', 'alprostadil', 'EUB0000980a', 'BA1000876']
Records Name['Prostaglandin E17-[3-Hydroxy-2-(3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', '(S)-7-[(R)-3-Hydroxy-2-((1R,2R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', 'SID144204033', '7-[(1R,2R,3R)-3-Hydroxy-2-((E)-(R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', '7-[(1R,3R)-3-Hydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', '(S)-7-[(R)-3-Hydroxy-2-((1R,2R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', '(S)-7-[(R)-3-Hydroxy-2-((1R,2R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', 'Alprostadil', 'Prostaglandin E1', '7-[(1R,2R,3R)-3-Hydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', '7-[3-Hydroxy-2-(3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', '7-[3-Hydroxy-2-(3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid', 'Alprostadil', '7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid', '7-((1R,2R,3R)-3-hydroxy-2-((S)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid', 'Prostaglandin E1', 'Prostaglandin E1', 'prostaglandin e1', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', 'Alprostadil', 'Prostaglandin E1', 'Prostaglandin E1', 'ALPROSTADIL', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostoglandin E1', 'Prostaglandin E1', 'Alprostadil', 'ALPROSTADIL', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', 'l-prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', 'Alprostadil', 'Alprostadil', 'Alprostadil脗', 'SID49681576', 'ALPROSTADIL', 'Prostaglandin E1', 'Alprostadil脢', 'ALPROSTADIL', 'alprostadil', 'alprostadil', 'ALPROSTADIL', 'ALPROSTADIL', 'ALPROSTADIL', 'ALPROSTADIL', 'ALPROSTADIL', 'C0164405', 'alprostadil', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', 'Prostaglandin E1', '7-((1R,2R,3R)-3-hydroxy-2-((S)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid', 'Prostaglandin E1', 'alprostadil', 'Prostaglandin E1', 'ALPROSTADIL']
Withdrawn FlagFalse
Orphan0

Molecular Structure

2D Molecular Structure